KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Free Cash Flow (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Free Cash Flow for 11 consecutive years, with $188.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 2.78% year-over-year to $188.1 million, compared with a TTM value of $681.9 million through Dec 2025, up 19.15%, and an annual FY2025 reading of $681.9 million, up 19.15% over the prior year.
  • Free Cash Flow was $188.1 million for Q4 2025 at Medpace Holdings, down from $235.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $235.5 million in Q3 2025 and bottomed at $37.0 million in Q1 2022.
  • Average Free Cash Flow over 5 years is $111.9 million, with a median of $104.6 million recorded in 2023.
  • The sharpest move saw Free Cash Flow plummeted 36.78% in 2021, then skyrocketed 108.58% in 2024.
  • Year by year, Free Cash Flow stood at $61.8 million in 2021, then skyrocketed by 106.29% to $127.4 million in 2022, then grew by 14.88% to $146.4 million in 2023, then increased by 25.01% to $183.0 million in 2024, then increased by 2.78% to $188.1 million in 2025.
  • Business Quant data shows Free Cash Flow for MEDP at $188.1 million in Q4 2025, $235.5 million in Q3 2025, and $142.4 million in Q2 2025.